FDA Adverse Event Injury Summary report: N

UNK MEDTRONIC DUREPAIR

MDR report key: 1691612 · Received May 14, 2010

Report

Report Number
2021898-2010-00091
Event Type
Injury
Date Received
May 14, 2010
Date of Event
February 1, 2010
Report Date
April 22, 2010
Manufacturer
MEDTRONIC NEUROSURGERY
Product Code
GXQ
PMA / PMN Number
K041000
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OR, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B) (4). THESE REPORTABLE EVENTS WERE IDENTIFIED DURING REVIEW OF SCIENTIFIC LITERATURE. THE ARTICLE CONTAINED ONLY LIMITED AND NON-SPECIFIC DEVICE AND PT INFORMATION. CONTACT WITH THE CORRESPONDING AUTHOR HAS BEEN UNSUCCESSFUL IN YIELDING ADDITIONAL INFORMATION ON INDIVIDUAL EVENTS. THE EVENTS REPORTED IN THE SOURCE LITERATURE COULD NOT BE MATCHED TO INFORMATION PREVIOUSLY REPORTED TO MEDTRONIC NEUROSURGERY. THE DESCRIBED POST-OPERATIVE CSF LEAKAGE RATE WAS WITHIN THE EXPECTED RANGE FOR DURAL GRAFTS. WEINSTEIN JS, LIU KC, DELASHAW JB, ET AL. THE SAFETY AND EFFECTIVENESS OF A DURAL SEALANT SYSTEM FOR USE WITH NONAUTOLOGOUS DURAPLASTY MATERIALS. J NEUROSURG 2000 FEBRUARY; 112:428-433.

Description of Event or Problem · 1

THE REVIEWED LITERATURE ARTICLE CONTAINED A STUDY OF 66 RETROSPECTIVELY REVIEWED SUBJECTS WHICH RECEIVED A COMMERCIAL DURAPLASTY MATERIAL USED WITH COMMERCIAL DURAL SEALANT SYSTEM. UNSPECIFIED MEDTRONIC DUREPAIR, DURA REGENERATION MATRIX, WAS USED AS THE PURAPLASTY MATERIAL IN 9 OF THE 66 PTS. THE SOURCE LITERATURE REPORTED THAT POSTOPERATIVE CSF LEAKS OCCURRED IN 5 OF THE 66 SUBJECTS. ALL THESE LEAKS WERE TREATED AND RESOLVED WITH NO RESIDUAL EFFECTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNK MEDTRONIC DUREPAIR GXQ MEDTRONIC NEUROSURGERY NA UNK

Patients

Seq Age Sex Outcome Treatment
1 53 YR Hospitalization| R